Navigation Links
Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
Date:12/20/2007

DA approval process; and the therapeutic and commercial value of Exelixis' compounds. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis' quarterly report on Form 10-Q for the quarter ended September 30, 2007 and Exelixis' other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Exelixis' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...NGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTec...nology, and medical-device research and,developmen... the United States,announced that it had been sel...9 list for the fifth consecutive year. The list re...,s technology, media, and telecommunications,indus...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNewswir...isher of scientific, medical and technical product...of Embase, its comprehensive biomedical,database w...re than 7,000,active, peer reviewed journals. ,...vancement of new biomedical,and pharmaceutical ins...
(Date:11/28/2009)... The Vanuatu National Advisory Committee on Clima...unication (SNC) Project in collaboration with the ...d. of New Zealand have generated preliminary clima...m the background for the country’s SNC repor... Climate Change (UNFCCC). , ...
(Date:11/27/2009)...ovember 27 Stallergenes ...ir(R) in both adults and children,through a Mutual... where,Oralair(R) has been marketed, was the refer...gistered in Austria, Belgium, Bulgaria, Cyprus, th..., Hungary, Ireland, Italy,Latvia, Lithuania, Luxe...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3
...Eye Hospital Program to Train Ophthalmology Reside...ngineers, NEW YORK, Aug. 25 ORBIS International,...in, China with its global,team of volunteer eye ca...er, Alcon, Inc. (NYSE: ACL ), the world,s leading...vincial Government, Heilongjiang Provincial,Health...
... Device Industry Experts Dodson and Tannenbaum Joi...Financial Officer, SUNNYVALE, Calif., Aug. 25 Av... has appointed medical device industry experts,Sco... (CEO), and Larry,Tannenbaum as Senior Vice Presid...ives will assume key roles with the Avantis manage...
... CITY, Calif. and MUMBAI, India, Aug. 25 ,Codexis,...ch Pharmalabs,Limited, a leading Indian active pha...anufacturer, today announced a major new strategic...ship in pharmaceuticals,manufacturing., Codexis, ...rmaceutical,intermediates and active pharmaceutica...
Other Biology Technology:ORBIS and Alcon Train China's Next Generation of Sight-Savers 2ORBIS and Alcon Train China's Next Generation of Sight-Savers 3ORBIS and Alcon Train China's Next Generation of Sight-Savers 4Avantis Medical Systems, Inc. Announces Key Leadership Appointments 2Codexis, Arch Announce Expanded Collaboration 2Codexis, Arch Announce Expanded Collaboration 3
(Date:11/30/2009)...e is available in German . , The DFG has ap...esearch Centres as of 1 January 2010. This decisio...ee in Bonn. The new centres will initially be fund...addition, 20 percent overhead funding for indirect... centres, research topics range from modern prosth...
(Date:11/30/2009)...of The Journal of Experimental Biology are pleas...ational de la Recherche Scientifique (CNRS) in the...of this year,s JEB Outstanding Paper Prize. ,The... achievement and is intended to encourage young sc...n-Chief, and adds that ,we truly appreciate when a...
(Date:11/30/2009)...mperatures continue to rise scientists are present... species respond and adapt. In a paper published i...o Rodriguez-Trelles and Dr Miguel Rodriguez assess...ing of approximately 0.6˚C has already affect...acing ecologists and evolutionary biologists is to...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4How can scientists measure evolutionary responses to climate change? 2Moles and melanoma researchers find genetic links to skin cancer 50761 1Moles and melanoma researchers find genetic links to skin cancer 50761 2New national genome center launched 9110 1New national genome center launched 9110 2New national genome center launched 9110 3Cardinal Health Renews Distribution Agreement With CVS Caremark 50753 1Cardinal Health Renews Distribution Agreement With CVS Caremark 50753 2Cardinal Health Renews Distribution Agreement With CVS Caremark 50753 3
... bone marrow cells that produce insulin appear to ...y that disables many people with diabetes, said a ... Houston. , The report from researchers at BCM, Sh...e University of Chicago appears online today in th... , The finding not only provides a basis for unde...
...covery of a vast ecosystem beneath the collapsed L...he uncharted life below Antarctica,s floating ice ...xtreme environments. Researchers discovered the su...y examining a deep glacial trough in the northwest...f collapse in 2002. , "This is definitely the bigg...
...t kills cancer can sneak past the blood brain barr...ces, to do its work in fighting a particularly inv... University animal study published in the Proceedi...ly Edition the week of Aug. 22. , "The bottom line...cure brain cancer," says William A. Banks, M.D., p...
Other Biology News:Malfunctioning bone marrow cells sabotage nerve cells in diabetes 2Discovering an ecosystem beneath a collapsed Antarctic ice shelf 2Slipping past the blood brain barrier: Research shows potential treatment for brain cancer 2
Rat Anti-Human CD66 acd Monoclonal Antibody, Unconjugated, Clone YTH71.3 from GeneTex
Anti-Mouse IgGAM Polyclonal Antibody, Horseradish Peroxidase Conjugated from Invitrogen
Mouse Anti-EGFr VIII Antibody, Unconjugated from Invitrogen
GIBCO Kanamycin Sulfate from Invitrogen
Biology Products: